Hemostat Market Analysis and Forecast to 2032: By Type (Combination Based Hemostats, Flowable Hemostat, Thrombin Based Hemostats, Oxidized Regenerated Cellulose-Based Hemostats, Gelatin Based Hemostats, Collagen Based Hemostats), Formulation (Matrix & Gel Hemostats, Sheet & Pad Hemostats, Sponge Hemostats, Powder Hemostats), Application (Orthopedic Surgery, General Surgery, Neurological Surgery, Cardiovascular Surgery, Reconstructive Surgery, Gynecological Surgery, and Others), End-use (Ambulatory Surgical Centers, Hospitals, Clinics, Community Healthcare), and Region
The Hemostats market size was nearly USD 3.5 Billion in 2022 and is anticipated to reach over USD 5.6 Billion in 2032, growing at a rate of nearly 5.0% from 2023 to 2032.
Hemostat is referred to a surgical agent that regulates and controls the bleeding process during surgical procedures. Hemostats help to shorten surgery time and reduces the need for blood transfusion. Hemostatic agents are essential in establishing hemostasis in pre-hospital conditions and preventing death associated with hemorrhage. Hemostats are used to compress blood vessels and prevent the flow of blood or other fluids. They are generally used in adjunct to surgical procedures to manage bleeding. Hemostatic agents offer different benefits, which include decreased wound healing & operative time, better management of anti-coagulated patients, and reduction in the patient recovery period.
Market Trends and Drivers
The growing demand for effective and efficient surgical and medical interventions, driven by an aging population and increasing instances of chronic diseases and traumatic injuries. As surgical procedures become more commonplace, there is a heightened emphasis on minimizing bleeding and improving patient outcomes, thereby escalating the need for advanced hemostatic products. Manufacturers are responding by developing innovative hemostats that offer quicker and more reliable hemostasis, reduced post-operative complications, and shorter recovery times. This trend is further supported by ongoing technological advancements in hemostatic agents, devices, and materials, all of which contribute to the expansion of the hemostat market.
Market Restraints and Challenges
Increasing scrutiny and regulatory challenges associated with product safety and efficacy. As hemostats play a crucial role in controlling bleeding during surgical procedures, ensuring their reliability and minimizing adverse effects is paramount. Stringent regulatory requirements, evolving standards, and the need for rigorous clinical evidence can lead to extended approval timelines and heightened development costs for manufacturers. Additionally, concerns about potential side effects, such as tissue damage or allergic reactions, may dampen physician and patient confidence, impacting the adoption of new hemostat products in the market. These challenges underscore the necessity for thorough testing, transparent reporting, and continuous monitoring to meet regulatory demands and establish the safety and effectiveness of hemostatic solutions.
Market Segments
The Hemostats market has been segmented into Product Type, Formulation, Application, End-use, and region. Based on Product Type, the global Hemostats market has been segmented into Combination Based Hemostats, Flowable Hemostat, Thrombin Based Hemostats, Oxidized Regenerated Cellulose-Based Hemostats, Gelatin Based Hemostats, and Collagen Based Hemostats. Based on Formulation, it is segmented into Matrix & Gel Hemostats, Sheet & Pad Hemostats, Sponge Hemostats, and Powder Hemostats. Based on Application, it is bifurcated into Orthopedic Surgery, General Surgery, Neurological Surgery, Cardiovascular Surgery, Reconstructive Surgery, Gynecological Surgery, and Others. On the basis of the End-use, the market is segmented into Ambulatory Surgical Centers, Hospitals, Clinics, and Community Healthcare. Region-wise, the market is analyzed across North America, Europe, Asia-Pacific, and Rest of the World.
Major Players in the Global Hemostats Market
The major players studied in the market are Baxter International Inc. (US), Ethicon (US), C.R. Bard (US), B. Braun Melsungen AG (Germany), Medtronic plc (Ireland), Teleflex Incorporated (US), Integra Life Sciences (US), Hemostasis, LLC (US), Pfizer Inc. (US), Stryker (US), CyroLife Inc. (US), Dalim Tissen, and GELITA MEDICAL GmbH (Germany) among others.
COVID-19 Impact
The COVID-19 pandemic has significantly impacted the hemostat market by generating both challenges and opportunities. While the pandemic led to disruptions in the global supply chain, limiting the availability of raw materials and hindering manufacturing processes, it also heightened the demand for hemostats in medical settings due to the surge in surgeries and treatments. The increased focus on infection prevention and the need to manage COVID-19-related complications have amplified the requirement for effective hemostatic products. As healthcare systems adapted to the crisis, telemedicine and remote patient monitoring gained prominence, influencing the distribution channels for hemostats. Despite initial setbacks, the market displayed resilience, adapting to the evolving healthcare landscape by incorporating technological advancements and novel distribution strategies.
Recent Developments
- July 2021, Medcura, Inc., a medical company together with ASO LLC, announced the launch of a new class of antibacterial hemostatic gel, Rapid-Seal. This product meets the market demand for a transparent gel that will be easily applied to injuries.
- February 2021, EndoClot Plus, Inc., announced that the company had received clearance for EndoClot Polysaccharide Hemostatic system from the U.S. Food and Drug Administration (FDA). This innovative product helps gastroenterologists to prevent bleeding rapidly. This technology represents a significant milestone in advancing the care of the G.I. patient.
- March 2020, Institute of Nano Science and Technology, an autonomous institute under the Department of Science & Technology, developed a starch based ‘hemostat’ material. This material helps in stopping the blood flow by concentrating the natural clotting factors in the blood.
- February 2020, Baxter announced 510(k) clearance from the US FDA for Peri-Strips Dry with Veritas Collagen Matrix product with Secure Grip. The product helps in mitigating bleeding during bariatric surgeries and other surgical procedures.
Hemostats Market Report Coverage
- The report offers a comprehensive quantitative as well as qualitative analysis of the current Hemostats Market outlook and estimations from 2022 to 2032, which helps to recognize the prevalent opportunities.
- The report also covers qualitative as well as quantitative analysis of Hemostats Market in terms of revenue ($Million).
- Major players in the market are profiled in this report and their key developmental strategies are studied in detail. This will provide an insight into the competitive landscape of the Hemostats Industry.
- A thorough analysis of market trends and restraints is provided.
- By region as well as country market analysis is also presented in this report.
- Analytical depiction of the Hemostats Market along with the current trends and future estimations to depict imminent investment pockets. The overall Hemostats industry opportunity is examined by understanding profitable trends to gain a stronger foothold.
- Porter’s five forces analysis, SWOT analysis, Pricing Analysis, Case Studies, COVID-19 impact analysis, Russia-Ukraine war impact, and PESTLE analysis of the Hemostats Market are also analyzed.
Table of Contents
Chapter 1. Hemostats Market Overview
1.1. Objectives of the Study
1.2. Market Definition and Research & Scope
1.3. Research Limitations
1.4. Research Methodologies
1.4.1. Secondary Research
1.4.2. Market Size Estimation Technique
1.4.3. Forecasting
1.4.4. Primary Research and Data Validation
Chapter 2. Executive Summary
2.1. Summary
2.2. Key Highlights of the Market
Chapter 3. Premium Insights on the Market
3.1. Market Attractiveness Analysis, by Product Type
3.2. Market Attractiveness Analysis, by Formulation
3.3. Market Attractiveness Analysis, by Application
3.4. Market Attractiveness Analysis, by End-use
3.5. Market Attractiveness Analysis, by Region
Chapter 4. Hemostats Market Outlook
4.1. Hemostats Market Segmentation
4.2. Market Dynamics
4.2.1. Market Drivers
4.2.1.1. Driver 1
4.2.1.2. Driver 2
4.2.1.3. Driver 3
4.2.2. Market Restraints
4.2.2.1. Restraint 1
4.2.2.2. Restraint 2
4.2.3. Market Opportunities
4.2.3.1. Opportunity 1
4.2.3.2. Opportunity 2
4.3. Porter’s Five Forces Analysis
4.3.1. Threat of New Entrants
4.3.2. Threat of Substitutes
4.3.3. Bargaining Power of Buyers
4.3.4. Bargaining Power of Supplier
4.3.5. Competitive Rivalry
4.4. PESTLE Analysis
4.5. Value Chain Analysis
4.6. Impact of COVID-19 on the Hemostats Market
4.7. Impact of the Russia and Ukraine War on the Hemostats Market
4.8. Case Study Analysis
4.9. Pricing Analysis
Chapter 5. Hemostats Market, by Product Type
5.1. Market Overview
5.2. Combination Based Hemostats
5.3. Thrombin Based Hemostats
5.4. Oxidized Regenerated Cellulose-Based Hemostats
5.5. Gelatin Based Hemostats
5.6. Collagen Based Hemostats
5.7. Flowable Hemostat
5.7.1. Key Market Trends & Opportunity Analysis
5.7.2. Market Size and Forecast, by Region
Chapter 6. Hemostats Market, by Formulation
6.1. Market Overview
6.2. Matrix & Gel Hemostats
6.2.1. Key Market Trends & Opportunity Analysis
6.2.2. Market Size and Forecast, by Region
6.3. Sheet & Pad Hemostats
6.3.1. Key Market Trends & Opportunity Analysis
6.3.2. Market Size and Forecast, by Region
6.4. Sponge Hemostats
6.4.1. Key Market Trends & Opportunity Analysis
6.4.2. Market Size and Forecast, by Region
6.5. Powder Hemostats
6.5.1. Key Market Trends & Opportunity Analysis
6.5.2. Market Size and Forecast, by Region
Chapter 7. Hemostats Market, by Application
7.1. Market Overview
7.2. Orthopedic Surgery
7.2.1. Key Market Trends & Opportunity Analysis
7.2.2. Market Size and Forecast, by Region
7.3. General Surgery
7.3.1. Key Market Trends & Opportunity Analysis
7.3.2. Market Size and Forecast, by Region
7.4. Neurological Surgery
7.4.1. Key Market Trends & Opportunity Analysis
7.4.2. Market Size and Forecast, by Region
7.5. Cardiovascular Surgery
7.5.1. Key Market Trends & Opportunity Analysis
7.5.2. Market Size and Forecast, by Region
7.6. Reconstructive Surgery
7.6.1. Key Market Trends & Opportunity Analysis
7.6.2. Market Size and Forecast, by Region
7.7. Gynecological Surgery
7.7.1. Key Market Trends & Opportunity Analysis
7.7.2. Market Size and Forecast, by Region
7.8. Others
7.8.1. Key Market Trends & Opportunity Analysis
7.8.2. Market Size and Forecast, by Region
Chapter 8. Hemostats Market, by End-use
8.1. Market Overview
8.2. Ambulatory Surgical Centers
8.2.1. Key Market Trends & Opportunity Analysis
8.2.2. Market Size and Forecast, by Region
8.3. Clinics
8.3.1. Key Market Trends & Opportunity Analysis
8.3.2. Market Size and Forecast, by Region
8.4. Community Healthcare
8.4.1. Key Market Trends & Opportunity Analysis
8.4.2. Market Size and Forecast, by Region
8.5. Hospitals
8.5.1. Key Market Trends & Opportunity Analysis
8.5.2. Market Size and Forecast, by Region
Chapter 9. Hemostats Market, by Region
9.1. Overview
9.2. North America
9.2.1. Key Market Trends and Opportunities
9.2.2. North America Hemostats Market Size and Forecast, by Product Type, 2022-2032
9.2.3. North America Hemostats Market Size and Forecast, by Formulation, 2022-2032
9.2.4. North America Hemostats Market Size and Forecast, by Application, 2022-2032
9.2.5. North America Hemostats Market Size and Forecast, by End-use, 2022-2032
9.2.6. North America Hemostats Market Size and Forecast, by Country
9.2.7. The U.S.
9.2.7.1. The U.S. Hemostats Market Size and Forecast, by Product Type, 2022-2032
9.2.7.2. The U.S. Hemostats Market Size and Forecast, by Formulation, 2022-2032
9.2.7.3. The U.S. Hemostats Market Size and Forecast, by Application, 2022-2032
9.2.7.4. The U.S. Hemostats Market Size and Forecast, by End-use, 2022-2032
9.2.8. Canada
9.2.8.1. Canada Hemostats Market Size and Forecast, by Product Type, 2022-2032
9.2.8.2. Canada Hemostats Market Size and Forecast, by Formulation Concentrators
9.2.8.3. Canada Hemostats Market Size and Forecast, by Application, 2022-2032
9.2.8.4. Canada Hemostats Market Size and Forecast, by End-use, 2022-2032
9.2.9. Mexico
9.2.9.1. Mexico Hemostats Market Size and Forecast, by Product Type, 2022-2032
9.2.9.2. Mexico Hemostats Market Size and Forecast, by Formulation, 2022-2032
9.2.9.3. Mexico Hemostats Market Size and Forecast, by Application, 2022-2032
9.2.9.4. Mexico Hemostats Market Size and Forecast, by End-use, 2022-2032
9.3. Europe
9.3.1. Key Market Trends and Opportunities
9.3.2. Europe Hemostats Market Size and Forecast, by Product Type, 2022-2032
9.3.3. Europe Hemostats Market Size and Forecast, by Formulation, 2022-2032
9.3.4. Europe Hemostats Market Size and Forecast, by Application, 2022-2032, 2022-2032
9.3.5. Europe Hemostats Market Size and Forecast, by End-use, 2022-2032
9.3.6. Europe Hemostats Market Size and Forecast, by Country
9.3.7. The UK
9.3.7.1. The UK Hemostats Market Size and Forecast, by Product Type, 2022-2032
9.3.7.2. The UK Hemostats Market Size and Forecast, by Formulation, 2022-2032
9.3.7.3. The UK Hemostats Market Size and Forecast, by Application, 2022-2032
9.3.7.4. The UK Hemostats Market Size and Forecast, by End-use, 2022-2032
9.3.8. Germany
9.3.8.1. Germany Hemostats Market Size and Forecast, by Product Type, 2022-2032
9.3.8.2. Germany Hemostats Market Size and Forecast, by Formulation, 2022-2032
9.3.8.3. Germany Hemostats Market Size and Forecast, by Application, 2022-2032
9.3.8.4. Germany Hemostats Market Size and Forecast, by End-use, 2022-2032
9.3.9. France
9.3.9.1. France Hemostats Market Size and Forecast, by Product Type, 2022-2032
9.3.9.2. France Hemostats Market Size and Forecast, by Formulation, 2022-2032
9.3.9.3. France Hemostats Market Size and Forecast, by Application, 2022-2032
9.3.9.4. France Hemostats Market Size and Forecast, by End-use, 2022-2032
9.3.10. Spain
9.3.10.1. Spain Hemostats Market Size and Forecast, by Product Type, 2022-2032
9.3.10.2. Spain Hemostats Market Size and Forecast, by Formulation, 2022-2032
9.3.10.3. Spain Hemostats Market Size and Forecast, by Application, 2022-2032
9.3.10.4. Spain Hemostats Market Size and Forecast, by End-use, 2022-2032
9.3.11. Italy
9.3.11.1. Italy Hemostats Market Size and Forecast, by Product Type, 2022-2032
9.3.11.2. Italy Hemostats Market Size and Forecast, by Formulation, 2022-2032
9.3.11.3. Italy Hemostats Market Size and Forecast, by Application, 2022-2032
9.3.11.4. Italy Hemostats Market Size and Forecast, by End-use, 2022-2032
9.3.12. Netherlands
9.3.12.1. Netherlands Hemostats Market Size and Forecast, by Product Type, 2022-2032
9.3.12.2. Netherlands Hemostats Market Size and Forecast, by Formulation, 2022-2032
9.3.12.3. Netherlands Hemostats Market Size and Forecast, by Application, 2022-2032
9.3.12.4. Netherlands Hemostats Market Size and Forecast, by End-use, 2022-2032
9.3.13. Sweden
9.3.13.1. Sweden Hemostats Market Size and Forecast, by Product Type, 2022-2032
9.3.13.2. Sweden Hemostats Market Size and Forecast, by Formulation, 2022-2032
9.3.13.3. Sweden Hemostats Market Size and Forecast, by Application, 2022-2032
9.3.13.4. Sweden Hemostats Market Size and Forecast, by End-use, 2022-2032
9.3.14. Switzerland
9.3.14.1. Switzerland Hemostats Market Size and Forecast, by Product Type, 2022-2032
9.3.14.2. Switzerland Hemostats Market Size and Forecast, by Formulation, 2022-2032
9.3.14.3. Switzerland Hemostats Market Size and Forecast, by Application, 2022-2032
9.3.14.4. Switzerland Hemostats Market Size and Forecast, by End-use, 2022-2032
9.3.15. Denmark
9.3.15.1. Denmark Hemostats Market Size and Forecast, by Product Type, 2022-2032
9.3.15.2. Denmark Hemostats Market Size and Forecast, by Formulation, 2022-2032
9.3.15.3. Denmark Hemostats Market Size and Forecast, by Application, 2022-2032
9.3.15.4. Denmark Hemostats Market Size and Forecast, by End-use, 2022-2032
9.3.16. Finland
9.3.16.1. Finland Hemostats Market Size and Forecast, by Product Type, 2022-2032
9.3.16.2. Finland Hemostats Market Size and Forecast, by Formulation, 2022-2032
9.3.16.3. Finland Hemostats Market Size and Forecast, by Application, 2022-2032
9.3.16.4. Finland Hemostats Market Size and Forecast, by End-use, 2022-2032
9.3.17. Russia
9.3.17.1. Russia Hemostats Market Size and Forecast, by Product Type, 2022-2032
9.3.17.2. Russia Hemostats Market Size and Forecast, by Formulation, 2022-2032
9.3.17.3. Russia Hemostats Market Size and Forecast, by Application, 2022-2032
9.3.17.4. Russia Hemostats Market Size and Forecast, by End-use, 2022-2032
9.3.18. Rest of Europe
9.3.18.1. Rest of Europe Hemostats Market Size and Forecast, by Product Type, 2022-2032
9.3.18.2. Rest of Europe Hemostats Market Size and Forecast, by Formulation, 2022-2032
9.3.18.3. Rest of Europe Hemostats Market Size and Forecast, by Application, 2022-2032
9.3.18.4. Rest of Europe Hemostats Market Size and Forecast, by End-use, 2022-2032
9.4. Asia-Pacific
9.4.1. Key Market Trends and Opportunities
9.4.2. Asia-Pacific Hemostats Market Size and Forecast, by Country
9.4.3. Asia-Pacific Hemostats Market Size and Forecast, by Product Type, 2022-2032
9.4.4. Asia-Pacific Hemostats Market Size and Forecast, by Formulation, 2022-2032
9.4.5. Asia-Pacific Hemostats Market Size and Forecast, by Application, 2022-2032
9.4.6. Asia-Pacific Hemostats Market Size and Forecast, by End-use, 2022-2032
9.4.7. China
9.4.7.1. China Hemostats Market Size and Forecast, by Product Type, 2022-2032
9.4.7.2. China Hemostats Market Size and Forecast, by Formulation, 2022-2032
9.4.7.3. China Hemostats Market Size and Forecast, by Application, 2022-2032
9.4.7.4. China Hemostats Market Size and Forecast, by End-use, 2022-2032
9.4.8. India
9.4.8.1. India Hemostats Market Size and Forecast, by Product Type, 2022-2032
9.4.8.2. India Hemostats Market Size and Forecast, by Formulation, 2022-2032
9.4.8.3. India Hemostats Market Size and Forecast, by Application, 2022-2032
9.4.8.4. India Hemostats Market Size and Forecast, by End-use, 2022-2032
9.4.9. Japan
9.4.9.1. Japan Hemostats Market Size and Forecast, by Product Type, 2022-2032
9.4.9.2. Japan Hemostats Market Size and Forecast, by Formulation, 2022-2032
9.4.9.3. Japan Hemostats Market Size and Forecast, by Application, 2022-2032
9.4.9.4. Japan Hemostats Market Size and Forecast, by End-use, 2022-2032
9.4.10. South Korea
9.4.10.1. South Korea Hemostats Market Size and Forecast, by Product Type, 2022-2032
9.4.10.2. South Korea Hemostats Market Size and Forecast, by Formulation, 2022-2032
9.4.10.3. South Korea Hemostats Market Size and Forecast, by Application, 2022-2032
9.4.10.4. South Korea Hemostats Market Size and Forecast, by End-use, 2022-2032
9.4.11. Australia
9.4.11.1. Australia Hemostats Market Size and Forecast, by Product Type, 2022-2032
9.4.11.2. Australia Hemostats Market Size and Forecast, by Formulation, 2022-2032
9.4.11.3. Australia Hemostats Market Size and Forecast, by Application, 2022-2032
9.4.11.4. Australia Hemostats Market Size and Forecast, by End-use, 2022-2032
9.4.12. Singapore
9.4.12.1. Singapore Hemostats Market Size and Forecast, by Product Type, 2022-2032
9.4.12.2. Singapore Hemostats Market Size and Forecast, by Formulation, 2022-2032
9.4.12.3. Singapore Hemostats Market Size and Forecast, by Application, 2022-2032
9.4.12.4. Singapore Hemostats Market Size and Forecast, by End-use, 2022-2032
9.4.13. Indonesia
9.4.13.1. Indonesia Hemostats Market Size and Forecast, by Product Type, 2022-2032
9.4.13.2. Indonesia Hemostats Market Size and Forecast, by Formulation, 2022-2032
9.4.13.3. Indonesia Hemostats Market Size and Forecast, by Application, 2022-2032
9.4.13.4. Indonesia Hemostats Market Size and Forecast, by End-use, 2022-2032
9.4.14. Taiwan
9.4.14.1. Taiwan Hemostats Market Size and Forecast, by Product Type, 2022-2032
9.4.14.2. Taiwan Hemostats Market Size and Forecast, by Formulation, 2022-2032
9.4.14.3. Taiwan Hemostats Market Size and Forecast, by Application, 2022-2032
9.4.14.4. Taiwan Hemostats Market Size and Forecast, by End-use, 2022-2032
9.4.15. Malaysia
9.4.15.1. Malaysia Hemostats Market Size and Forecast, by Product Type, 2022-2032
9.4.15.2. Malaysia Hemostats Market Size and Forecast, by Formulation, 2022-2032
9.4.15.3. Malaysia Hemostats Market Size and Forecast, by Application, 2022-2032
9.4.15.4. Malaysia Hemostats Market Size and Forecast, by End-use, 2022-2032
9.4.16. Rest of APAC
9.4.16.1. Rest of APAC Hemostats Market Size and Forecast, by Product Type, 2022-2032
9.4.16.2. Rest of APAC Hemostats Market Size and Forecast, by Formulation, 2022-2032
9.4.16.3. Rest of APAC Hemostats Market Size and Forecast, by Application, 2022-2032
9.4.16.4. Rest of APAC Hemostats Market Size and Forecast, by End-use, 2022-2032
9.5. Rest of The World
9.5.1. Key Market Trends and Opportunities
9.5.2. Rest of The World Hemostats Market Size and Forecast, by Product Type, 2022-2032
9.5.3. Rest of The World Hemostats Market Size and Forecast, by Formulation, 2022-2032
9.5.4. Rest of The World Hemostats Market Size and Forecast, by Application, 2022-2032
9.5.5. Rest of The World Hemostats Market Size and Forecast, by End-use, 2022-2032
9.5.6. Rest of The World Hemostats Market Size and Forecast, by Country
9.5.7. Latin America
9.5.7.1. Latin America Hemostats Market Size and Forecast, by Product Type, 2022-2032
9.5.7.2. Latin America Hemostats Market Size and Forecast, by Formulation, 2022-2032
9.5.7.3. Latin America Hemostats Market Size and Forecast, by Application, 2022-2032
9.5.7.4. Latin America Hemostats Market Size and Forecast, by End-use, 2022-2032
9.5.8. Middle East
9.5.8.1. Middle East Hemostats Market Size and Forecast, by Product Type, 2022-2032
9.5.8.2. Middle East Hemostats Market Size and Forecast, by Formulation, 2022-2032
9.5.8.3. Middle East Hemostats Market Size and Forecast, by Application, 2022-2032
9.5.8.4. Middle East Hemostats Market Size and Forecast, by End-use, 2022-2032
9.5.9. Africa
9.5.9.1. Africa Hemostats Market Size and Forecast, by Product Type, 2022-2032
9.5.9.2. Africa Hemostats Market Size and Forecast, by Formulation, 2022-2032
9.5.9.3. Africa Hemostats Market Size and Forecast, by Application, 2022-2032
9.5.9.4. Africa Hemostats Market Size and Forecast, by End-use, 2022-2032
Chapter 10. Competitive Landscape
10.1. Overview
10.2. Market Share Analysis/Key Player Positioning
10.3. Vendor Benchmarking
10.4. Developmental Strategy Benchmarking
10.4.1. New Product Developments
10.4.2. Product Launches
10.4.3. Business Expansions
10.4.4. Partnerships, Joint Ventures, and Collaborations
10.4.5. Mergers and Acquisitions
Chapter 11. Company Profiles
11.1. Baxter International Inc. (US)
11.1.1. Company Snapshot
11.1.2. Financial Performance
11.1.3. Product Offerings
11.1.4. Key Developmental Strategies
11.1.5. SWOT Analysis
11.2. B. Braun Melsungen AG (Germany)
11.2.1. Company Snapshot
11.2.2. Financial Performance
11.2.3. Product Offerings
11.2.4. Key Developmental Strategies
11.2.5. SWOT Analysis
11.3. Integra Life Sciences (US)
11.3.1. Company Snapshot
11.3.2. Financial Performance
11.3.3. Product Offerings
11.3.4. Key Developmental Strategies
11.3.5. SWOT Analysis
11.4. Hemostasis, LLC (US)
11.4.1. Company Snapshot
11.4.2. Financial Performance
11.4.3. Product Offerings
11.4.4. Key Developmental Strategies
11.4.5. SWOT Analysis
11.5. Ethicon (US)
11.5.1. Company Snapshot
11.5.2. Financial Performance
11.5.3. Product Offerings
11.5.4. Key Developmental Strategies
11.5.5. SWOT Analysis
11.6. C.R. Bard (US)
11.6.1. Company Snapshot
11.6.2. Financial Performance
11.6.3. Product Offerings
11.6.4. Key Developmental Strategies
11.6.5. SWOT Analysis
11.7. Pfizer Inc. (US)
11.7.1. Company Snapshot
11.7.2. Financial Performance
11.7.3. Product Offerings
11.7.4. Key Developmental Strategies
11.7.5. SWOT Analysis
11.8. Stryker (US)
11.8.1. Company Snapshot
11.8.2. Financial Performance
11.8.3. Product Offerings
11.8.4. Key Developmental Strategies
11.8.5. SWOT Analysis
11.9. CyroLife Inc. (US)
11.9.1. Company Snapshot
11.9.2. Financial Performance
11.9.3. Product Offerings
11.9.4. Key Developmental Strategies
11.9.5. SWOT Analysis
11.10. GELITA MEDICAL GmbH (Germany)
11.10.1. Company Snapshot
11.10.2. Financial Performance
11.10.3. Product Offerings
11.10.4. Key Developmental Strategies
11.10.5. SWOT Analysis
11.11. Dalim Tissen.
11.11.1. Company Snapshot
11.11.2. Financial Performance
11.11.3. Product Offerings
11.11.4. Key Developmental Strategies
11.11.5. SWOT Analysis
11.12. Johnson & Johnson
11.12.1. Company Snapshot
11.12.2. Financial Performance
11.12.3. Product Offerings
11.12.4. Key Developmental Strategies
11.12.5. SWOT Analysis
*The list of companies is subject to change during the final compilation of the report
Key Players
Global Hemostat Market Segmentation
By Product Type
- Combination Based Hemostats
- Thrombin Based Hemostats
- Oxidized Regenerated Cellulose-Based Hemostats
- Gelatin Based Hemostats
- Collagen Based Hemostats
- Flowable Hemostat
By Formulation
- Matrix & Gel Hemostats
- Sheet & Pad Hemostats
- Sponge Hemostats
- Powder Hemostats
By Application
- Orthopedic Surgery
- General Surgery
- Neurological Surgery
- Cardiovascular Surgery
- Reconstructive Surgery
- Gynecological Surgery
- Others
By End-use
- Ambulatory Surgical Centers
- Clinics
- Community Healthcare
- Hospitals
By Region
- North America
- The U.S.
- Canada
- Mexico
- Europe
- The U.K.
- Germany
- France
- Spain
- Italy
- Netherlands
- Sweden
- Switzerland
- Denmark
- Finland
- Russia
- Rest of Europe
- The Asia-Pacific
- China
- India
- Japan
- South Korea
- Australia
- Singapore
- Indonesia
- Taiwan
- Malaysia
- Rest of Asia-Pacific
- Rest of the World
- Latin America
- The Middle East
- Africa